Enhancing traditional marketing and sales practice, with a science-driven approach, has helped the global oncology division achieve an increase of 15 – 25% in leading KPIs including new scripts, within 6 months.

A leading provider in the US market of medical imaging devices, related disposable parts and consumable substances, wanted to streamline its operations to grow market share while increasing efficiency of the field and home office teams. Read how Verix helped them to boost sales by 18% and improve efficiency by 15%.

The introduction of a first product is a key milestone in the life of a young pharmaceutical company. IronShore needed the confidence of partnering with an experienced vendor, with in-depth life science domain expertise, that with minimal strain on their resources will be able to design and deploy an efficient and reliable, process-driven solution and overcome unexpected obstacles that more often than not pop up in a newcomer’s first launch.

When Bayer US Pharma, was about to launch two new high profile Oncology drugs, the need for a cutting edge, agile analysis solution was a prerequisite to guarantee success in this competitive market. Verix was chosen after a careful selection process, to support the sensitive and complicated launch process of these specialty products.

In April 2014, Bayer pharmaceuticals completed the acquisition of Algeta, a long time independent partner specializing in pharmaceutical sales. In attempt to streamline operations and reduce expenses, Bayer strived to eliminate unnecessary redundancy between their in-house and third party sales forces. The anticipated advantages of merging the two sales forces have been obvious for over two years, yet Bayer’s sales operations managers were hesitant to kick off the merger, fearing a long and painful process that will cause, every sales’ manager’s nightmare, an inevitable dip in sales.